{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:45:12Z","timestamp":1786538712722,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.radonc.2025.111243","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T07:29:09Z","timestamp":1762068549000},"page":"111243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Brachytherapy (Interventional Radiotherapy) for lip carcinoma: excellent local control, low toxicity profile, and high patient satisfaction \u2013 The Dutch experience from four brachytherapy-dedicated head and neck cancer centers"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0748-6640","authenticated-orcid":false,"given":"Abrahim","family":"Al-Mamgani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-6544","authenticated-orcid":false,"given":"Gerda M.","family":"Verduijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1727-8215","authenticated-orcid":false,"given":"Ellen","family":"Zwijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem H.","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniel","family":"Sewnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Weijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Tans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homan","family":"Dehnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9386-7011","authenticated-orcid":false,"given":"Lia","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-7807","authenticated-orcid":false,"given":"Arash","family":"Navran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Karssemakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mischa","family":"de Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111243_b0005","unstructured":"Dutch Cancer Registration. Nederlandse Kankerregistratie (NKR). 2021. iknl.nl\/nkr-cijfers."},{"key":"10.1016\/j.radonc.2025.111243_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110533","article-title":"GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR","volume":"201","author":"Guinot","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111243_b0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5114\/jcb.2024.143223","article-title":"COMIRI - COMplexity Index of interventional Radiotherapy (brachytherapy) Implants: assessment of procedures based on type, equipment, and team","volume":"16","author":"Fionda","year":"2024","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2025.111243_b0020","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.joms.2008.09.020","article-title":"Surgical treatment of lip cancer: our experience with 106 cases","volume":"67","author":"Salgarelli","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.radonc.2025.111243_b0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000637-200301000-00008","article-title":"Management of lower lip cancer: a retrospective analysis of 118 patients and review of the literature","volume":"50","author":"Bilkay","year":"2003","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.radonc.2025.111243_b0030","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/odi.14723","article-title":"Long-term outcomes, quality of life, and costs of treatment modalities for T1\u2013T2 lip carcinomas","volume":"30","author":"van Hof","year":"2024","journal-title":"Oral Dis"},{"key":"10.1016\/j.radonc.2025.111243_b0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.joms.2006.03.054","article-title":"Surgical management of squamous cell carcinoma of the lip: analysis of a 10-year experience in 223 patients","volume":"65","author":"Vukadinovic","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.radonc.2025.111243_b0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/2000656X.2016.1270215","article-title":"Lip carcinoma: clinical presentation, surgical treatment, and outcome: a series of 108 cases from Denmark","volume":"51","author":"Kristensen","year":"2017","journal-title":"J Plast Surg Hand Surg"},{"key":"10.1016\/j.radonc.2025.111243_b0045","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/(SICI)1097-0347(199909)21:6<526::AID-HED5>3.0.CO;2-B","article-title":"A comparison of results after radiotherapy and surgery for stage I squamous cell carcinoma of the lower lip","volume":"21","author":"de Visscher","year":"1999","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2025.111243_b0050","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1016\/j.ijrobp.2010.10.031","article-title":"Brachytherapy in lip carcinoma: long-term results","volume":"81","author":"Guibert","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111243_b0055","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.brachy.2013.05.007","article-title":"From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications","volume":"12","author":"Guinot","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.111243_b0060","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ijrobp.2011.09.038","article-title":"High dose-rate versus low dose-rate brachytherapy for lip cancer","volume":"83","author":"Ghadjar","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111243_b0065","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/hed.27936","article-title":"\u201cHigh-risk\u201d tumors of the lip treated with external beam radiotherapy and high-dose-rate brachytherapy: long-term outcome","volume":"47","author":"Mercke","year":"2025","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2025.111243_b0070","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) (cancer.gov)."},{"key":"10.1016\/j.radonc.2025.111243_b0075","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.4317\/medoral.19595","article-title":"Surgical management of squamous cell carcinoma of the lower lip: an experience of 109 cases","volume":"19","author":"Rena","year":"2014","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.radonc.2025.111243_b0080","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1007\/s00405-014-3415-6","article-title":"Squamous cell carcinoma of the lip: survival analysis with long-term follow-up","volume":"272","author":"Ozturk","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.radonc.2025.111243_b0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3892\/ol.2022.13594","article-title":"Treatment outcomes of squamous cell carcinoma of the lip: a retrospective study","volume":"25","author":"Babu","year":"2022","journal-title":"Oncol Lett"},{"key":"10.1016\/j.radonc.2025.111243_b0090","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2016.01.041","article-title":"Lip cancer: a clinicopathological study and treatment outcomes in a 25-year experience","volume":"74","author":"Biasoli","year":"2016","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.radonc.2025.111243_b0095","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/cancers13061387","article-title":"Pulsed dose rate brachytherapy of lip carcinoma: clinical outcome and quality of life analysis","volume":"13","author":"El Ayachy","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.111243_b0100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5114\/jcb.2013.37777","article-title":"Pulsed dose rate brachytherapy of lip cancer","volume":"5","author":"Serkies","year":"2013","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2025.111243_b0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5114\/jcb.2011.23199","article-title":"Long term results of PDR brachytherapy for lip cancer","volume":"3","author":"Johansson","year":"2011","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2025.111243_b0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5114\/jcb.2019.84687","article-title":"Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection","volume":"11","author":"Chyrek","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2025.111243_b0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.brachy.2023.02.001","article-title":"High-dose-rate brachytherapy at 3 Gy per fraction for lip carcinoma: Treatment outcomes and toxicity at 5-years","volume":"22","author":"Tu\u010dek","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.111243_b0120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/fpsam.2022.0170","article-title":"Long-term appearance-related outcomes of facial reconstruction after skin cancer resection","volume":"25","author":"Gulati","year":"2023","journal-title":"Facial Plast Surg Aesthet Med"},{"key":"10.1016\/j.radonc.2025.111243_b0125","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaoto.2021.1563","article-title":"Patient-reported aesthetic and psychosocial outcomes after microvascular reconstruction for head and neck cancer","volume":"147","author":"Zebolsky","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2025.111243_b0130","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1038\/s41467-021-26472-9","article-title":"Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma","volume":"12","author":"Vos","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.radonc.2025.111243_b0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJMoa2415434","article-title":"Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer","volume":"393","author":"Uppaluri","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:26:25Z","timestamp":1786537585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025052478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"alternative-id":["S0167814025052478"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111243","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brachytherapy (Interventional Radiotherapy) for lip carcinoma: excellent local control, low toxicity profile, and high patient satisfaction \u2013 The Dutch experience from four brachytherapy-dedicated head and neck cancer centers","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111243"}}